Citadel Advisors’s Inspire Corporate Bond ETF IBD Stock Holding History
Bought
Maintained
Sold
Other funds holding IBD
IA
FA
CFD
BFS
II
OFS
PFG
PAW
UCFA
Citadel Advisors's IBD Position: Q2 2026 in Review
Citadel Advisors reduced its Inspire Corporate Bond ETF (IBD) stake by 57% in Q2 2026, selling an estimated $3.12M and leaving 97,889 shares worth $2.33M. The position accounts for ﹤0.01% of the portfolio, ranked #6225.
Citadel Advisors first reported a position in IBD in Q4 2019 and has held it in 20 quarters since. The position peaked at $6.29M in Q2 2021. 110 funds tracked by Wall St. Rank hold IBD as of Q2 2026.
- Citadel Advisors held 97,889 shares of Inspire Corporate Bond ETF worth $2.33M as of Q2 2026.
- Citadel Advisors sold 130,875 Inspire Corporate Bond ETF shares in Q2 2026, an estimated $3.12M.
- Inspire Corporate Bond ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #6225 holding.
- Citadel Advisors first reported a position in Inspire Corporate Bond ETF in Q4 2019 and has held it in 20 quarters since.
- Citadel Advisors's Inspire Corporate Bond ETF position peaked at $6.29M in Q2 2021.
- 110 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.